1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31779
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFowler, Christopher J-
dc.contributor.authorStoops, Erik-
dc.contributor.authorRainey-Smith, Stephanie R-
dc.contributor.authorVanmechelen, Eugeen-
dc.contributor.authorVanbrabant, Jeroen-
dc.contributor.authorDewit, Nele-
dc.contributor.authorMauroo, Kimberley-
dc.contributor.authorMaruff, Paul-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorFripp, Jurgen-
dc.contributor.authorLi, Qiao-Xin-
dc.contributor.authorBourgeat, Pierrick-
dc.contributor.authorCollins, Steven J-
dc.contributor.authorMartins, Ralph N-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorDoecke, James D-
dc.date2022-
dc.date.accessioned2023-01-12T03:02:34Z-
dc.date.available2023-01-12T03:02:34Z-
dc.date.issued2022-
dc.identifier.citationAlzheimer's and Dementia 2022en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31779-
dc.description.abstractIn Alzheimer's disease (AD), plasma amyloid beta (Aβ)1-42 and phosphorylated tau (p-tau) predict high amyloid status from Aβ positron emission tomography (PET); however, the extent to which combination of these plasma assays can predict remains unknown.en_US
dc.language.isoeng-
dc.subjectAlzheimer's diseaseen_US
dc.subjectamyloid beta amyloid imagingen_US
dc.subjectblood biomarkersen_US
dc.subjectblood diagnostic for Alzheimer's diseaseen_US
dc.subjectcerebrospinal fluiden_US
dc.subjectphosphorylated tauen_US
dc.subjectplasma amyloid betaen_US
dc.subjectplasma phosphorylated tau181en_US
dc.subjectpositron emission tomographyen_US
dc.titlePlasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAlzheimer's and Dementiaen_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen_US
dc.identifier.affiliationADx NeuroSciences Ghent Belgium.en_US
dc.identifier.affiliationSchool of Medical and Health Sciences Centre of Excellence for Alzheimer's Disease Research & Care Edith Cowan University Joondalup Western Australia Australia.en_US
dc.identifier.affiliationCogstate Ltd Melbourne Victoria Australia.en_US
dc.identifier.affiliationAustralian E-Health Research Centre CSIRO Herston Queensland Australia.en_US
dc.identifier.affiliationDepartment of Medicine (RMH) The University of Melbourne Melbourne Victoria Australia.en_US
dc.identifier.doi10.1002/dad2.12375en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-2863-0293en_US
dc.identifier.pubmedid36447478-
dc.description.volume14-
dc.description.issue1-
dc.description.startpagee12375-
local.name.researcherMasters, Colin L
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.